Page last updated: 2024-10-31

clorgyline and Neoplasms

clorgyline has been researched along with Neoplasms in 1 studies

Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duan, YC1
Ma, YC1
Qin, WP1
Ding, LN1
Zheng, YC1
Zhu, YL1
Zhai, XY1
Yang, J1
Ma, CY1
Guan, YY1

Other Studies

1 other study available for clorgyline and Neoplasms

ArticleYear
Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment.
    European journal of medicinal chemistry, 2017, Nov-10, Volume: 140

    Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Histone Deacetylase Inhibitors;

2017